newsfilter
← Latest News
PR Newswire·

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial...